To address the complicated healthcare landscape in the U.S., Pfizer launched a new direct-to-consumer virtual service called PfizerForAll. It follows Eli Lilly, which launched a similar product in January.
Biopharmaceutical company Pfizer is starting to serve consumers directly through its new telehealth platform called PfizerForAll, the company announced Tuesday. Pfizer declared that the platform is needed as consumers battle a confusing healthcare system.
PfizerForAll will support patients with conditions like migraines, Covid-19 or the flu. Through the platform, users can connect with independent healthcare professionals via telehealth or in person. They can also receive prescription medicines, over-the-counter treatments and diagnostic tests delivered to their home, or accessible at their local pharmacy.
In addition, adult consumers can use the platform to find availability for Covid-19, flu, RSV and pneumococcal vaccines and book an appointment. Consumers can use their existing insurance and pharmacy programs, and they can access customer support for help with their insurance. PfizerForAll was also launched in partnership with several healthcare organizations, including UpScriptHealth, Alto Pharmacy and Instacart, though the company declined to say the partners’ roles.